Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - jack+arbiser
6
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Indolium 1 for Advanced Melanoma Treatment
Application A small molecule compound for the treatment of melanoma. Key Benefits Novel small molecule compound for the treatment of resistant melanoma. Well tolerated in vivo. Market Summary Malignant melanoma is a type of skin cancer that begins in melanocyte cells. Melanoma is the 19th most commonly occurring cancer. Exposure to UV radiation...
Published: 2/5/2026
|
Inventor(s):
Jack Arbiser
Keywords(s):
Oncology Treatments
,
Small Molecule
Category(s):
TechPub Algolia > Therapeutics
Small Molecule Inhibitors for the Treatment of COVID-19 Infection
Application Small molecule therapy to treat patients infected with COVID-19 virus. Key Benefits Current FDA-approved therapeutic can be repurposed to fight COVID-19 infection. Treatment option for infected COVID-19 patients. Market Summary Coronavirus (COVID-19) is an infectious disease that causes severe acute respiratory syndrome coronavirus...
Published: 10/3/2025
|
Inventor(s):
Jack Arbiser
,
Martijn van Hemert
,
Melissa Thaler
Keywords(s):
COVID19
,
Microbiology and Infectious Disease Treatments
,
Repurposed Drug
,
Small Molecule
Category(s):
TechPub Algolia > Therapeutics
Targeted Anti-Cancer Nanoparticle Therapy
Application A drug-carrying nanoparticle that selectively targets cancer cells. Key Benefits Incorporates an already proven anti-cancer therapeutic. Increases deliverability. Targets cancer cells. Market Summary Tris DBA palladium has been shown to have anti-cancer activity against melanoma and pancreatic cancer. However, Tris DBA has not...
Published: 2/24/2026
|
Inventor(s):
Jack Arbiser
,
Lily Yang
Keywords(s):
Oncology Treatments
,
Repurposed Drug
Category(s):
TechPub Algolia > Therapeutics
,
TechPub Algolia > Micro and Nanotechnology
Small Molecule NOX Inhibitors of Human Melanoma Cell Proliferation
Application Triphenylmethane small molecules inhibiting NADPH oxidase (NOX) for the anti-proliferation of melanoma tumor cells. Key Benefits Modifies molecular interactions with cellular proteins, reducing cell tumor growth. Compounds are capable of inhibiting cell proliferation to a greater extent than current competing NOX inhibitors for melanoma...
Published: 9/26/2024
|
Inventor(s):
Jack Arbiser
Keywords(s):
Dermatology
,
Oncology
,
Small Molecule
Category(s):
TechPub Algolia > Therapeutics
DHAA and Derivatives for Treatment of BRAF-V600E-Positive Cancer
Application Hypolipidemic dehydroacetic acid (DHAA) treatment to prevent growth of BRAF V600E positive tumors. Key Benefits Treatment with slows BRAF V600E-positive tumor growth. Repurposed compound may speed FDA approval. May be used in combination with other therapies. Market Summary Up to 50% of melanoma cases harbor the BRAF V600E mutation,...
Published: 1/20/2026
|
Inventor(s):
Jing Chen
,
Jack Arbiser
,
Brian Pollack
,
Siyuan Xia
Keywords(s):
Enzyme and Protein Research
,
Oncology Treatments
,
Repurposed Drug
Category(s):
TechPub Algolia > Therapeutics
Small Molecule Derivatives of Solenopsin for Cancer Treatment
ApplicationSmall molecule analogs of the naturally-occurring compound solenopsin for the treatment of various cancers including melanoma and angiosarcoma.Key BenefitsAnalogs derived from a naturally-occurring alkaloid. Potential treatment of cancers for which there is a poor prognosis or low survival rate. Market SummaryPhosphoinositol-3 kinase (PI3K)...
Published: 1/20/2026
|
Inventor(s):
Jack Arbiser
,
J. Phillip Bowen
,
E. Blake Watkins
Keywords(s):
Oncology Treatments
,
Small Molecule
Category(s):
TechPub Algolia > Therapeutics